Get the Stockscreener App
16.87
0.84%
0.14
After Hours:
16.81
-0.06
-0.36%
Acadia Pharmaceuticals Inc Stock (ACAD) Forecast
The Acadia Pharmaceuticals Inc (ACAD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $37.31, representing a +121.19% increase from the current price of $16.87. The highest analyst price target is $43.02, and the lowest is $31.60.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACAD Price Target
Average 36.22
(+114.73% Upside)
Is Acadia Pharmaceuticals Inc (ACAD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.60 | Neutral |
| STOCH(9,6) | 26.14 | Neutral |
| STOCHRSI(14) | 6.9079 | Buy |
| MACD(12,26) | 0.2158 | Sell |
| ADX(14) | 18.18 | Neutral |
| William %R | -74.79 | Neutral |
| CCI(14) | -50.87 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.51
Sell
|
17.14
Sell
|
| MA20 |
17.04
Sell
|
17.04
Sell
|
| MA50 |
16.22
Buy
|
16.58
Buy
|
| MA100 |
16.08
Buy
|
16.52
Buy
|
| MA200 |
16.51
Buy
|
17.87
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ACAD could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ACAD, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.6 indicates that ACAD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.14 indicates that ACAD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.9079 indicates that ACAD is oversold. This suggests that ACAD price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.87 indicates that ACAD is still oversold but not to an extreme extent.
Long-term ACAD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acadia Pharmaceuticals Inc financial reports and earnings history, Acadia Pharmaceuticals Inc (ACAD) stock could reach $9.1774 by 2030, $2.3212 by 2040 and $9.6681 by 2050. See the projected annual prices until 2050 of the Acadia Pharmaceuticals Inc stock below:
- Acadia Pharmaceuticals Inc (ACAD) is expected to reach an average price of $10.19 in 2035, with a high prediction of $13.43 and a low estimate of $9.4427. This indicates an $-39.58% rise from the last recorded price of $16.87.
- Acadia Pharmaceuticals Inc (ACAD) stock is projected to chart a bullish course in 2040, with an average price target of $2.1612, representing an $-87.19% surge from its current level. The forecast ranges from a conservative $0.7312 to a sky-high $2.3212.
- Our analysts predict Acadia Pharmaceuticals Inc (ACAD) to jump -37.21% by 2045, soaring from $10.34 to an average price of $10.59, potentially reaching $9.4723. While $10.34 is the low estimate, the potential upside is significant.
- Acadia Pharmaceuticals Inc (ACAD) stock is expected to climb by 2050, reaching an average of $9.8776, a $-41.45% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.6681 and $10.57, respectively, highlighting the market's uncertainty.
Acadia Pharmaceuticals Inc Stock (ACAD) Year by Year Forecast
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2025
Acadia Pharmaceuticals Inc Stock (ACAD) is expected to reach an average price of $36.22 in 2025, with a high prediction of $50.65 and a low estimate of $21.80. This indicates an +114.73% rise from the last recorded price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $31.96 | $31.60 | $43.02 | +89.45% |
| February, 2025 | $31.51 | $28.72 | $38.88 | +86.81% |
| March, 2025 | $33.04 | $29.04 | $39.71 | +95.88% |
| April, 2025 | $34.01 | $21.80 | $36.87 | +101.57% |
| May, 2025 | $41.63 | $30.28 | $43.00 | +146.77% |
| June, 2025 | $42.71 | $36.12 | $44.57 | +153.14% |
| July, 2025 | $43.69 | $36.38 | $45.01 | +158.95% |
| August, 2025 | $47.42 | $38.87 | $50.65 | +181.06% |
| September, 2025 | $34.74 | $32.82 | $48.27 | +105.90% |
| October, 2025 | $30.33 | $28.85 | $34.95 | +79.76% |
| November, 2025 | $33.35 | $28.39 | $34.71 | +97.66% |
| December, 2025 | $38.60 | $32.51 | $40.15 | +128.79% |
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2026
The predicted value for Acadia Pharmaceuticals Inc (ACAD) in 2026 is set at an average of $28.99. Estimates vary from a peak of $49.65 to a trough of $8.3268, indicating an +71.82% surge from the present price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $48.19 | $36.94 | $49.65 | +185.63% |
| February, 2026 | $47.48 | $42.47 | $49.46 | +181.42% |
| March, 2026 | $45.93 | $43.30 | $49.58 | +172.24% |
| April, 2026 | $44.05 | $37.95 | $46.87 | +161.09% |
| May, 2026 | $20.11 | $15.70 | $44.45 | +19.19% |
| June, 2026 | $12.79 | $12.71 | $20.68 | -24.20% |
| July, 2026 | $14.22 | $11.64 | $14.78 | -15.73% |
| August, 2026 | $19.91 | $13.08 | $20.09 | +18.00% |
| September, 2026 | $16.25 | $15.70 | $20.18 | -3.69% |
| October, 2026 | $11.76 | $11.49 | $17.05 | -30.31% |
| November, 2026 | $10.13 | $8.5974 | $12.41 | -39.97% |
| December, 2026 | $9.2877 | $8.3268 | $10.66 | -44.95% |
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acadia Pharmaceuticals Inc (ACAD) is $13.20, with a high forecast of $21.04 and a low forecast of $5.3489. This indicates an -21.78% decrease from the last price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.26 | $9.2327 | $11.28 | -33.27% |
| February, 2027 | $11.90 | $9.5978 | $14.62 | -29.47% |
| March, 2027 | $18.56 | $11.28 | $19.13 | +10.01% |
| April, 2027 | $15.89 | $13.64 | $20.00 | -5.82% |
| May, 2027 | $16.48 | $13.60 | $16.90 | -2.32% |
| June, 2027 | $16.97 | $16.37 | $20.71 | +0.58% |
| July, 2027 | $17.19 | $14.71 | $20.35 | +1.89% |
| August, 2027 | $13.44 | $13.36 | $21.04 | -20.34% |
| September, 2027 | $10.14 | $8.1987 | $13.53 | -39.90% |
| October, 2027 | $12.61 | $8.6289 | $13.45 | -25.26% |
| November, 2027 | $8.879 | $5.3489 | $9.099 | -47.37% |
| December, 2027 | $9.5892 | $6.9791 | $10.16 | -43.16% |
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2028
In 2028, Acadia Pharmaceuticals Inc (ACAD) is projected to reach an average price of $13.38, with a high projection of $19.69 and a low estimate of $7.0596. This indicates an -20.72% fall from the last price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.9593 | $8.8793 | $10.87 | -40.96% |
| February, 2028 | $9.6294 | $9.2094 | $11.57 | -42.92% |
| March, 2028 | $9.3496 | $8.3695 | $12.06 | -44.58% |
| April, 2028 | $8.4697 | $7.0596 | $10.11 | -49.79% |
| May, 2028 | $8.8798 | $7.8398 | $9.5298 | -47.36% |
| June, 2028 | $12.80 | $8.4999 | $12.83 | -24.13% |
| July, 2028 | $12.46 | $11.84 | $13.67 | -26.14% |
| August, 2028 | $13.91 | $12.02 | $15.39 | -17.54% |
| September, 2028 | $11.93 | $11.49 | $14.38 | -29.28% |
| October, 2028 | $15.55 | $11.30 | $15.66 | -7.82% |
| November, 2028 | $18.28 | $14.05 | $19.69 | +8.36% |
| December, 2028 | $17.66 | $17.06 | $19.23 | +4.69% |
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2029
The 2029 price forecast for Acadia Pharmaceuticals Inc Stock (ACAD) is $17.79 on average, with a high prediction of $27.73 and a low estimate of $7.8422. This represents an +5.43% increase from the previous price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $23.00 | $17.39 | $27.73 | +36.34% |
| February, 2029 | $22.40 | $19.89 | $24.29 | +32.79% |
| March, 2029 | $18.56 | $18.51 | $22.47 | +10.02% |
| April, 2029 | $17.02 | $14.18 | $20.17 | +0.90% |
| May, 2029 | $16.13 | $15.51 | $19.50 | -4.38% |
| June, 2029 | $16.57 | $15.55 | $17.33 | -1.77% |
| July, 2029 | $25.32 | $14.75 | $26.59 | +50.10% |
| August, 2029 | $19.97 | $19.73 | $25.84 | +18.39% |
| September, 2029 | $18.88 | $17.63 | $20.87 | +11.93% |
| October, 2029 | $12.10 | $12.06 | $20.67 | -28.26% |
| November, 2029 | $11.01 | $10.79 | $12.80 | -34.72% |
| December, 2029 | $8.3336 | $7.8422 | $11.79 | -50.60% |
Acadia Pharmaceuticals Inc Stock (ACAD) Price Forecast for 2030
Acadia Pharmaceuticals Inc Stock (ACAD) is expected to reach an average price of $20.64 in 2030, with a high forecast of $36.93 and a low forecast of $4.3478. This signifies an +22.34% surge from the last price of $16.87.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.1625 | $6.5774 | $9.1774 | -57.54% |
| February, 2030 | $10.07 | $6.9376 | $10.49 | -40.34% |
| March, 2030 | $11.40 | $4.3478 | $12.12 | -32.44% |
| April, 2030 | $10.36 | $10.23 | $13.23 | -38.60% |
| May, 2030 | $19.01 | $6.9833 | $27.81 | +12.68% |
| June, 2030 | $24.62 | $18.38 | $27.19 | +45.93% |
| July, 2030 | $30.33 | $22.86 | $31.40 | +79.78% |
| August, 2030 | $28.56 | $25.57 | $36.93 | +69.29% |
| September, 2030 | $28.57 | $22.67 | $30.56 | +69.35% |
| October, 2030 | $29.64 | $20.42 | $31.44 | +75.70% |
| November, 2030 | $17.66 | $15.74 | $30.74 | +4.68% |
| December, 2030 | $24.16 | $13.57 | $28.06 | +43.21% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):